- Part 11: For the preceding part double click ID:nRSH4027Rj
marketing channels and route to market; and interventions by national
governments or regulators restricting market access and/or introducing
adverse price controls.
Challenges to achieving commercial success of new products Impact
The successful launch of a new pharmaceutical product involves If a new product does not succeed as anticipated or its rate of sales growth is slower than anticipated, there is a risk that we may be unable to fully recoup the costs incurred in launching it, which could materially adversely affect our business or results of operations.Due to the complexity of the commercialisation process for biologics, the methods of distributing and marketing biologics could materially adversely impact our revenues from the sales of biologics medicines, such as Synagis and FluMist/Fluenz.
substantial investment in sales and marketing activities, launch stocks
and other items. The commercial success of our new medicines is
particularly important to replace lost Product Sales following patent
expiry. We may ultimately be unable to achieve commercial success for any
number of reasons. These include difficulties in manufacturing sufficient
quantities of the product candidate for development or commercialisation
in a timely manner, the impact of price control measures imposed by
- More to follow, for following part double click ID:nRSH4027Rl